| Pubmed | 32989256 |
| Title: | Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA. |
| Year: | 2020 |
| DOI: | https://doi.org/10.1038/s41388-020-01482-x |
| First Author: | Xu |
| Experimental setup: | affinity chromatography technology (Biogrid) |
| Throughput: | High Throughput (Biogrid)
Low Throughput (Biogrid) |